|
16/10/2009 16:38 (35 Day 19:47 minutes ago) | |
|
The FINANCIAL -- Biosense Webster, Inc., one of the worldwide leaders in the diagnosis and treatment of cardiac arrhythmias, announced on October 15 that the U.S. Food and Drug Administration (FDA) has cleared for marketing the CARTO 3 System, the most advanced three-dimensional imaging technology for use by electrophysiologists in treating cardiac arrhythmias, commonly referred to as irregular heart rhythms. |
|
| Read more... | |
|
|
|
|
|
|
|
|
|
|||||
|


